Kantonsspital St.Gallen, Onkologie/Hämatologie

Sankt Gallen 9007

0 studies enrolling now · 6 studies all time

What they study most

Bladder Cancer, Breast Cancer, Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer, Prostatic Neoplasms, Castration-Resistant, Tumors

Studies at this site

• PALbociclib CoLlaborative Adjuvant Study — Running, not enrolling
• A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen — Completed
• A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) — Completed
• A Study of Atezolizumab in Advanced Solid Tumors — Completed
• A Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Completed
• A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211] — Completed